“Reflections on the Scope of Rights Holders in Securities Representative Litigation: — Insights from the Kangmei Pharmaceutical Case”. 法学年鉴, vol. 1, no. 2, May 2026, pp. 70–75, https://doi.org/10.63313/Law.8020.